Overview

OMAR Opioid Use Disorder

Status:
Recruiting

Trial end date:
2025-12-15

Target enrollment:

Participant gender:

Summary

The goal of this research study is to examine the endocannabinoid (eCB) function in vivo in individuals with opioid use disorder (OUD) by measuring cannabinoid receptor 1 (CB1R) availability.

Phase:

Phase 1

Details

Lead Sponsor:

Yale University

Collaborator:

National Institute on Drug Abuse (NIDA)